Curium
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
2 Seaport Ln Fl 2, Boston, Massachusetts...Phone Number
(866) 789-2211Website
www.curiumpharma.comRevenue
$1.1 BillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
2
2
1
1
About Curium
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. We strive to innovate further in nuclear diagnostics and therapies so we can enhance the lives of people with cancer.
Every day we see the impact that our treatments offer and the potential they have to provide a world beyond cancer and other debilitating conditions. We continue to push boundaries and reach new heights in everything we do, supported by significant investment into new technologies and therapies.Explore more
Curium Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Curium recently announced quarterly report
Check out if Curium is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Curium
Click to see if Curium had a recent Job posting/layoffs
Curium, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Curium has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Curium has new funding data
Product Launch: Get notified when Curium launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Curium is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Curium is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Curium.
Curium financials insights
Gather financial insights about Curium, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$265M
2022
Debt
$335M
Curium Tech Stack
A closer look at the technologies used by Curium
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Open Position
Open Position
Open Position
Curium News & Media
Curium deepens radiopharma heft with up to $8 billion deal for Lantheus
Aug 3 (Reuters) - Radiopharmaceutical company Curium has agreed to buy peer Lantheus Holdings in a deal worth up to $8 billion, as the private equity-backed firm looks to expand its footprint in the fast-growing sector. Radiopharmaceuticals, which use radioactive compounds to diagnose and treat diseases such as cancer, have become one of the hottest areas in healthcare dealmaking.Curium advances plans for second investment in Romania to expand access to advanced nuclear medicine
Curium advances plans for a second cyclotron in Romania, supporting greater access to PET imaging and nuclear medicine services.Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs
Curium has reintroduced Thallium-201 in the U.S., restoring access to a key nuclear cardiology imaging agent.Curium Announces a Strategic Investment of Over €32 million in Saclay, France
PARIS, June 01, 2026 (GLOBE NEWSWIRE) -- Curium, a global leader in nuclear medicine, today announced at the Choose France summit in Versailles, a major industrial investment program in France to the value of €32 million. This investment will strengthen its production capabilities for radiopharmaceuticals through the creation of a new production line, and 20 highly skilled jobs. This will supply the European market with ¹⁷⁷Lu-PSMA-I&T, a targeted radioligand therapy (RLT) for patients with metas
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curium
Sign Up For FreeTo access detailed company insights
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. We strive to innovate further in nuclear diagnostics and therapies so we can enhance the lives of people with cancer. Every day we see the impact that our treatments offer and the potential they have to provide a worl... Read More
